PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Aug-2024 Ainos to Participate in Fireside Chat with Water Tower Research on August 22, 2024 AccessWire
12-Aug-2024 MIRA Pharmaceuticals Unveils Ketamir-2's Principal Metabolite: Nor-Ketamir - a Longer-Acting, Brain Penetrating and Selective Compound Acting on the NMDA PCP Receptor AccessWire
12-Aug-2024 R1 RCM Named Top Performing Revenue Cycle Management Outsourcing Provider by 2024 Black Book Health Systems Client Survey AccessWire
12-Aug-2024 Interactive Strength Inc. (Nasdaq: TRNR) Wins Appeal for Continued Nasdaq Listing AccessWire
12-Aug-2024 Theralase(R) Release’s 2Q2024 Financial Statements AccessWire
12-Aug-2024 Q&M Dental Group's profit after tax grew 84%, Board declared 0.40 cent interim dividend, a 150% increase over the same period last year Q&M Dental Group Ltd
12-Aug-2024 Biopharmaceuticals Market is Predicted to Reach $974 Billion with a CAGR of 12% by 2030 Next Move Strategy Consulting
12-Aug-2024 Antibody Therapy Market Is Likely to Experience a Tremendous Growth in Near Future Acumen Research and Consulting
09-Aug-2024 Ainos Secures Exclusive Multi-Regions Invention Patent Licenses from Strategic Partner to Bolster AI Nose and Point-Of-Care Testing AccessWire
09-Aug-2024 Xtant Medical Announces Closing of $5.0 Million Private Placement AccessWire
09-Aug-2024 Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2024 Nxera Pharma
09-Aug-2024 Levicept Announces Positive Results of Phase II Trial of novel Neurotrophin-3 Inhibitor, LEVI-04, for the Treatment of Patients with Moderate to Severe Osteoarthritis Levicept
09-Aug-2024 Valneva Scotland Receives Prestigious Award for Health and Safety Excellence Valneva
09-Aug-2024 Subsidiaries of Vita 34 reach agreement with US licensor Vita 34 AG
09-Aug-2024 Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024 AccessWire
09-Aug-2024 Lantern Pharma Announces Positive Clinical Update from Ongoing Phase 2 HARMONIC™ Clinical Trial for Never Smokers with Advanced NSCLC, Including an 86% Clinical Benefit Rate in the Initial Patient Cohort Lantern Pharma
09-Aug-2024 MedEvolve Rated Top Revenue Cycle Management Workflow Optimization and Automation Solution, 2024 Black Book RCM Client Survey AccessWire
09-Aug-2024 FSD Pharma Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this Month - Created by a World-Class Pharmaceutical Research & Development Team AccessWire
09-Aug-2024 Next Health Celebrates Eight Years of Pioneering Proactive Healthcare, Commits to Continued Innovation and Growth AccessWire
09-Aug-2024 Eckert & Ziegler Continues Sales and Earnings Growth in the First Half of 2024 Eckert & Ziegler SE